Debates between Sally-Ann Hart and Barbara Keeley during the 2019 Parliament

Medical Cannabis (Access) Bill

Debate between Sally-Ann Hart and Barbara Keeley
Friday 10th December 2021

(2 years, 4 months ago)

Commons Chamber
Read Full debate Read Hansard Text
Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

Yes, I absolutely agree with what my hon. Friend says, and I will be coming to the call for evidence a little bit later in my speech—

Barbara Keeley Portrait Barbara Keeley
- Hansard - - - Excerpts

Will the hon. Lady give way?

Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

Can I just finish one sentence?

I will be coming back to the need for more evidence and for manufacturing businesses to come forward, because there is huge potential. There is huge potential for manufacturing businesses and pharmaceutical companies to come forward with evidence to expand the amount of cannabis-based products that will and should be available on prescription from the NHS, so that the mothers who are trying their best for their young people and children are not having to pay a fortune to get this medicine privately.

Barbara Keeley Portrait Barbara Keeley
- Hansard - - - Excerpts

It is obvious to see what is going on here—Government Members are trying to talk out the Bill—but an argument was made in the previous intervention that we needed more evidence. This Bill would provide that, because it would bring forward a commission that would consolidate evidence and give a suitable framework for assessing cannabis products. That is what it is all about. Government Members worried about evidence should vote for the Bill.

Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

I just want—

--- Later in debate ---
Barbara Keeley Portrait Barbara Keeley
- Hansard - - - Excerpts

Will the hon. Lady give way?

Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

I will give way in a minute.

We already have legislation and pathways in place. The Government have made big inroads on facilitating cannabis-based products for NHS prescription. We are on the path. Do you think primary legislation will force the hand of pharmaceutical companies or manufacturing businesses to bring forward products for clinical trials?

--- Later in debate ---
Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

Thank you, Madam Deputy Speaker. I understand that we have to use the right terminology because it depersonalises the debate, which is most important.

I am not sure whether I answered the intervention by the hon. Member for Gower (Tonia Antoniazzi), but I had better move on.

Barbara Keeley Portrait Barbara Keeley
- Hansard - - - Excerpts

The hon. Lady is talking about needing a debate on the Bill, but that debate could happen in Committee. All the points that Conservative Members are making—excruciatingly slowly to spin out the time and talk out the Bill—could happen there. The way that the legislative process works is that we get to Second Reading and vote for the Bill, then the details that Conservative Members are so keen to bring up now can be thrashed out in Committee. Let us make some progress.

Sally-Ann Hart Portrait Sally-Ann Hart
- Hansard - -

I thank the hon. Lady for her intervention, but if we only had debate in Committee, many hon. Members would not get to put forward their view, because they might not be on that Committee.